Humana Inc (NYSE:HUM) – Analysts at Leerink Swann lifted their FY2018 earnings per share (EPS) estimates for shares of Humana in a report issued on Thursday. Leerink Swann analyst A. Gupte now anticipates that the insurance provider will earn $14.00 per share for the year, up from their previous estimate of $12.25. Leerink Swann currently has a “Outperform” rating and a $300.00 target price on the stock. Leerink Swann also issued estimates for Humana’s FY2019 earnings at $17.50 EPS and FY2020 earnings at $19.40 EPS.
A number of other analysts also recently commented on the stock. Deutsche Bank boosted their price objective on shares of Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a report on Friday. Oppenheimer upped their price target on shares of Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a report on Thursday. Credit Suisse Group raised shares of Humana from a “neutral” rating to an “outperform” rating and reduced their price target for the company from $264.90 to $246.00 in a report on Thursday. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, February 7th. Finally, Zacks Investment Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 19th. Eight research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $269.68.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $2.00 by $0.06. The firm had revenue of $13.19 billion for the quarter, compared to the consensus estimate of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The firm’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.34 earnings per share.
Large investors have recently bought and sold shares of the company. WFG Advisors LP raised its position in shares of Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after buying an additional 20 shares during the last quarter. Fieldpoint Private Securities LLC acquired a new position in shares of Humana in the third quarter valued at approximately $115,000. ClariVest Asset Management LLC acquired a new position in shares of Humana in the third quarter valued at approximately $144,000. Daiwa SB Investments Ltd. raised its position in shares of Humana by 44.9% in the fourth quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after buying an additional 220 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Humana in the fourth quarter valued at approximately $204,000. 94.13% of the stock is owned by institutional investors and hedge funds.
In other news, SVP Jody L. Bilney sold 7,054 shares of the business’s stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the completion of the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the completion of the transaction, the vice president now directly owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. In the last three months, insiders sold 10,115 shares of company stock valued at $2,501,627. Company insiders own 0.80% of the company’s stock.
Humana declared that its Board of Directors has approved a stock repurchase program on Thursday, December 14th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. Humana’s payout ratio is currently 9.59%.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.